MALIK FADY IBRAHAM (EVP Research & Development) sold 7.3% of their position (12.03K shares) of CYTOKINETICS INC on the open market
Open‑market sale worth $747.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/18/2026ACC: 0001061983-26-000027
Officer· EVP Research & Development
Since Jul 2018
-12.03K
Net shares
Net seller
$747.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
12.03K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−7.64K
Price / share
$62.15
Trade value
$474.58K
% of position
4.6%
3/17/2026
165.94K→158.30K
Common Stock
Direct
Shares
−4.40K
Price / share
$62.15
Trade value
$273.27K
% of position
2.8%
3/17/2026
158.30K→153.90K
Total
Net shares
−12.03K
Net value
-$747.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2026 | S · Sale | −7.64K | $62.15 | $474.58K | 4.6% | 165.94K | 158.30K |
| Common Stock Direct | 3/17/2026 | S · Sale | −4.40K | $62.15 | $273.27K | 2.8% | 158.30K | 153.90K |
| Total | −12.03K | -$747.85K | ||||||
Derivative Transactions0
No derivative transactions reported